Foghorn Therapeutics Statistics
Total Valuation
FHTX has a market cap or net worth of $306.38 million. The enterprise value is $148.63 million.
Important Dates
The next estimated earnings date is Thursday, March 5, 2026, after market close.
| Earnings Date | Mar 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
FHTX has 58.58 million shares outstanding. The number of shares has increased by 26.52% in one year.
| Current Share Class | 58.58M |
| Shares Outstanding | 58.58M |
| Shares Change (YoY) | +26.52% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 7.65% |
| Owned by Institutions (%) | 37.56% |
| Float | 28.87M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 13.42 |
| Forward PS | 10.05 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.16
| Current Ratio | 2.16 |
| Quick Ratio | 2.12 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -21.07% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -72.17% |
| Weighted Average Cost of Capital (WACC) | 19.48% |
| Revenue Per Employee | $218,911 |
| Profits Per Employee | -$643,946 |
| Employee Count | 112 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +27.25% in the last 52 weeks. The beta is 3.03, so FHTX's price volatility has been higher than the market average.
| Beta (5Y) | 3.03 |
| 52-Week Price Change | +27.25% |
| 50-Day Moving Average | 5.25 |
| 200-Day Moving Average | 4.89 |
| Relative Strength Index (RSI) | 42.73 |
| Average Volume (20 Days) | 204,355 |
Short Selling Information
The latest short interest is 1.18 million, so 2.01% of the outstanding shares have been sold short.
| Short Interest | 1.18M |
| Short Previous Month | 1.13M |
| Short % of Shares Out | 2.01% |
| Short % of Float | 4.08% |
| Short Ratio (days to cover) | 5.88 |
Income Statement
In the last 12 months, FHTX had revenue of $24.52 million and -$72.12 million in losses. Loss per share was -$1.15.
| Revenue | 24.52M |
| Gross Profit | -59.41M |
| Operating Income | -86.52M |
| Pretax Income | -72.12M |
| Net Income | -72.12M |
| EBITDA | -83.23M |
| EBIT | -86.52M |
| Loss Per Share | -$1.15 |
Full Income StatementBalance Sheet
The company has $180.28 million in cash and $22.53 million in debt, with a net cash position of $157.75 million or $2.69 per share.
| Cash & Cash Equivalents | 180.28M |
| Total Debt | 22.53M |
| Net Cash | 157.75M |
| Net Cash Per Share | $2.69 |
| Equity (Book Value) | -89.66M |
| Book Value Per Share | -1.59 |
| Working Capital | 99.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$88.35 million and capital expenditures -$529,000, giving a free cash flow of -$88.88 million.
| Operating Cash Flow | -88.35M |
| Capital Expenditures | -529,000 |
| Free Cash Flow | -88.88M |
| FCF Per Share | -$1.52 |
Full Cash Flow StatementMargins
Gross margin is -242.31%, with operating and profit margins of -352.87% and -294.16%.
| Gross Margin | -242.31% |
| Operating Margin | -352.87% |
| Pretax Margin | -294.16% |
| Profit Margin | -294.16% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FHTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.52% |
| Shareholder Yield | -26.52% |
| Earnings Yield | -23.54% |
| FCF Yield | -29.01% |
Analyst Forecast
The average price target for FHTX is $11.43, which is 118.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.43 |
| Price Target Difference | 118.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 29.13% |
| EPS Growth Forecast (5Y) | -34.54% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FHTX has an Altman Z-Score of -4.26 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.26 |
| Piotroski F-Score | 2 |
